Showing results (201-210 of 687) with videos related to
Sort By:
Pageof 69
Journal of Bone Oncology|November 29, 2023
Targeting transforming growth factor beta signaling in metastatic osteosarcomaRongrong Ge, Gavin M HuangJournal of Bone Oncology|November 29, 2023
Novel_circ_003686 regulates the osteogenic differentiation of MSCs in patients with myeloma bone disease through miR-142-5p/IGF1 axisLing Qiu, Lei Ma, Dan Chen, et al.Journal of Bone Oncology|September 4, 2023
DXA assessment and fracture prevention in hormone positive breast cancer patients after treatment initiation with aromatase inhibitors: A registry-based cohort studyVanessa Rouach, Yona Greenman, Gabriel Chodick, et al.Journal of Bone Oncology|September 13, 2023
A randomized trial comparing LY01011, biosimilar candidate, with the reference product denosumab (Xgeva®) in healthy Chinese subjectsYanhua Ding, Yusi Liu, Changlin Dou, et al.Journal of Bone Oncology|July 17, 2023
MAT2A inhibits the ferroptosis in osteosarcoma progression regulated by miR-26b-5pShuchi Xia, Yun Liang, Yuqing Shen, et al.Journal of Bone Oncology|February 12, 2019
Bone metastasis pattern of cancer patients with bone metastasis but no visceral metastasisMingyu Zhu, Xin Liu, Yuan Qu, et al.Journal of Bone Oncology|February 22, 2020
Exosomes derived from bone marrow mesenchymal stem cells promote osteosarcoma development by activating oncogenic autophagyYao Huang, Wei Liu, Bing He, et al.Journal of Bone Oncology|November 4, 2020
Adoptive transfer of TILs plus anti-PD1 therapy: An alternative combination therapy for treating metastatic osteosarcomaChao Wang, Ming Li, Rong Wei, et al.Journal of Bone Oncology|October 22, 2020
Limb-salvage surgery offers better five-year survival rate than amputation in patients with limb osteosarcoma treated with neoadjuvant chemotherapy. A systematic review and meta-analysisEvgenia Papakonstantinou, Alexandros Stamatopoulos, Dimitrios I Athanasiadis, et al.Journal of Bone Oncology|October 19, 2020
Expression profiling of DNA methyl transferase I (DNMT1) and efficacy of a DNA-hypomethylating agent (decitabine) in combination with chemotherapy in osteosarcomaParunya Chaiyawat, Nutnicha Sirikaew, Piyaporn Budprom, et al.Pageof 69